PPT-HIGH RESOLUTION PROTEOMICS AND GENOMICS OF CNDP1 REPEAT VARIANTS LINKED TO DIABETIC NEPHROPATHY

Parviz Shabane Ramu Anandakrishnan Arichanah Pulenthiran Harold Garner CNDP1 is an excreted dipeptidase that exists as a monomer or homodimer Its two substrates are Hcarnosine preferred and . InSAR. : Where Have We Been and Where Are We Going? . Howard . Zebker. , Cody . Wortham. Stanford University. 10 Years Ago: Where Were We?. Anticipated several . new . space . radar . systems for monitoring . Bioinformatics and Genomics. Applications:. Personalized cancer medicines. Disease determination . Pathway Analysis. Biomarker Discovery . An Interesting Point. “One . article estimated that the output from genomics may soon dwarf data heavyweights such as . Patel University. Efficacy of Urinary N-Acetyl β- D- Glucosaminidase in Detecting Renal Tubular Damage: A Early Consequence in Type 2 Diabetes Mellitus leading to Diabetic Nephropathy. Kiran. . Sierra Nevada Nephrology Consultants. Outline. Define the illness. Recent state of Affairs. Pathology. Risk factors. Medication. Treatments. Diabetic nephropathy is a clinical . syndrome. Persistent . IN. TYPE I DIABETIC NEPHROPATHY. DR.NASIM MUSA. Type I –IDDM is characterized by. The abrupt onset of symptoms. Insulinopenia. Dependence on injected insulin for life. Proneness to . ketoacidosis. .. kidney disease . in . diabetes :. In . either . type 1 or . type 2 diabetes : . 25 – 40. % . → diabetic . nephropathy in a 25 . y. Diabetes . → leading cause for ESRD. diabetic . nephropathy :. . nodushan. Fellow of endocrinology. Research institute for endocrine sciences. . . Shahid. . Beheshti. University of Medical Sciences.. Jul.2017. Agenda. Prevalence. Natural history . Overview and Capabilities: . . High Throughput Sequencing Facility (HTSG). Functional Genomics M. ammalian Genotyping Core (MGC). Corbin Jones. Faculty Director. Piotr . Meiczkowski . Technologies . Rescues C9-ALS/FTD Molecular Hallmarks . In Vivo. and . In Vitro. Katharina E. Meijboom. 1. , Nicholas Fordham. 1. , Meghan Blackwood. 1. , Gabriela Toro Cabrera. 1. , Robert H. Brown. 2. , Christian Mueller. From ESH 2016 | LB 1:. Jean-Pierre . Fauvel. , MD. CHU Lyon, . Hôpital. E Herriot, Lyon, . France. Overview. Online risk prediction tool created to aid optimizing treatment of diabetic nephropathy. Egypt Rheumatol Rehab Vol. 30. No. 3, May, 2003 367Hemoglobin A is specifically eluted after washing away the HbA1fraction, and is quantified by direct photometric reading at 4/5 nm. The columns we 5 5 DOI: 10.7860/JCDR/2018/36574.12203 Original Article Miscellaneous Postgraduate Education Letter to Editor Short Communication Images in Medicine Experimental Research Clinician’s corner Revie Rodica. Pop-. Busui. , M.D., . Ph.D. Division of Metabolism, Endocrinology and Diabetes. Michigan Comprehensive Diabetes Center. University of . Michigan. Diabetes is the dominant cause of ESRD in USA. . Shahin. . Nosratzehi. . volume . 14 | JUNE 2018 | . 361. Agenda. Introduction. Classical phenotype. Mechanisms of . DKD. Immediate effects of . hyperglycemia. Late effects of . hyperglycemia. Non-protein uric phenotype.